LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$57,000
+29.5%
330
-6.0%
0.00%
Q2 2021$44,000
+2.3%
351
+4.2%
0.00%
Q4 2020$43,000
+13.2%
3370.0%0.00%
Q3 2020$38,000
+18.8%
3370.0%0.00%
Q2 2020$32,000
+6.7%
3370.0%0.00%
-100.0%
Q1 2020$30,000
+66.7%
3370.0%0.00%
Q4 2019$18,000
+38.5%
3370.0%0.00%
Q3 2019$13,000
-7.1%
3370.0%0.00%
Q2 2019$14,000
-12.5%
3370.0%0.00%
Q1 2019$16,000
+6.7%
3370.0%0.00%
Q4 2018$15,000
-21.1%
3370.0%0.00%
Q3 2018$19,000
+18.8%
3370.0%0.00%
Q2 2018$16,000
+23.1%
3370.0%0.00%
Q1 2018$13,000
-7.1%
3370.0%0.00%
Q4 2017$14,000
+7.7%
3370.0%0.00%
Q3 2017$13,000
+18.2%
3370.0%0.00%
Q2 2017$11,000
+22.2%
3370.0%0.00%
Q1 2017$9,0000.0%3370.0%0.00%
Q4 2016$9,000
-25.0%
3370.0%0.00%
Q3 2016$12,000
+9.1%
3370.0%0.00%
Q2 2016$11,0003370.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,080,113$50,301,0004.98%
Foresite Capital Management II, LLC 188,602$8,783,0003.96%
Artal Group S.A. 1,650,000$76,841,0003.14%
Foresite Capital Management III, LLC 254,923$11,872,0003.09%
Asymmetry Capital Management, L.P. 30,125$1,403,0002.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,255,174$58,453,0002.24%
QVT Financial LP 190,977$8,894,0002.24%
SECTORAL ASSET MANAGEMENT INC 269,396$12,546,0001.51%
Novo Holdings A/S 198,261$9,233,0001.37%
FARALLON CAPITAL MANAGEMENT LLC 2,375,000$110,604,0000.83%
View complete list of ACCELERON PHARMA INC shareholders